Healthcare Roundup – Lysol use approved by EPA against COVID-19, Glaxo teams up with Medicago Life Science
Healthcare Roundup – Unum Therapeutics completes Kiq buy, Becton, Dickinson launches COVID-19 rapid test in U.S. Life Science
Healthcare Roundup – FDA OKs ViiV Healthcare’s fostemsavir, UNITY Biotechnology announces upcoming catalysts for its lead programs Life Science
Healthcare Roundup – Regeneron, Sanofi dip, Fauci says don’t ‘balance lives against the economy’ Life Science
Healthcare Roundup – T2 Biosystems launches COVID-19 molecular diagnostic test, CytoDyn down 32% Life Science
Healthcare Roundup – Gilead prices remdesivir at $390 per vial, RedHill Biopharma to launch late-stage study of opaganib in COVID-19 Life Science
Healthcare Roundup – European advisory backs Gilead’s remdesivir for COVID-19, Ekso Bionics shares rocket Life Science
Healthcare Roundup – UniQure out-licenses hemophilia B gene therapy, Bad COVID news is good news for COVID vaccine & drugmakers Life Science
Healthcare Roundup – AstraZeneca up modestly on positive COVID-19 vaccine news, Pot stocks rally on Aurora Cannabis reboot actions Life Science
Healthcare Roundup – FDA OKs new formulation of Regeneron and Sanofi’s Dupixent, COVID blows keep coming – Phillies close training facilities Life Science
Healthcare Roundup – AbbVie nixes microbiome GI program collaboration, Alpha Pro Tech pops Life Science
Healthcare Roundup – FDA yanks emergency use authorization of Chembio COVID-19 blood test, Gilead readies pediatric study of remdesivir Life Science
Healthcare Roundup – COVID-19 treatment, economic news push futures even higher, COVID hospitalizations on the rise in Texas Life Science
